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Background: NF45-NF90 and NF45-NF110 
possess double-stranded RNA binding 
domains. 
Results: NF45-NF90 and NF45-NF110 
occupy the c-fos gene dynamically and 
enhance its transcriptional induction by 
extracellular stimuli. 
Conclusion: NF45-NF90 and NF45-NF110 
function as coactivators and are involved in 
various steps of gene expression. 
Significance: Analysis of RNA-binding 
coactivators is important for understanding 
the coordination among different steps of 
gene expression. 
 
SUMMARY 
  The c-fos gene is rapidly induced to high 
levels by various extracellular stimuli. We 
used a defined in vitro transcription system 
that utilizes the c-fos promoter to purify a 
coactivator activity in an unbiased manner. 
We report here that NF45-NF90 and 
NF45-NF110, which possess archetypical 
double-stranded RNA binding motifs, have 
a direct function as transcriptional 
coactivators. The transcriptional activities 
of the NF complexes (NF45-NF90 and 
NF45-NF110) are mediated by both the 
upstream enhancer and core promoter 
regions of the c-fos gene and do not 
require their double-stranded 
RNA-binding activities. The NF complexes 
cooperate with general coactivators, PC4 
and Mediator, to elicit a high level of 
transcription and display multiple 
interactions with activators and the 
components of the general transcriptional 
machinery. Knockdown of the endogenous 
NF90/NF110 in mouse cells shows an 
important role for the NF complexes in 
inducing c-fos transcription. Chromatin 
immunoprecipitation assays demonstrate 
that the NF complexes occupy the c-fos 
enhancer/promoter region before and after 
serum induction and that their 
occupancies within the coding region of 
the c-fos gene increase in parallel to that of 
RNAPII upon serum induction. In light of 
their dynamic occupancy on the c-fos gene 
as well as direct functions in both 
transcription and posttranscriptional 
processes, the NF complexes appear to 
serve as multifunctional coactivators that 
coordinate different steps of gene 
expression to facilitate rapid response of 
inducible genes.                       
  The c-fos gene is an immediate early gene 
that is induced rapidly by diverse 
extracellular signals including growth factors, 
cytokines and cellular stress (1). These 
signals are transmitted via cascades of 
kinases to transcriptional activators such as 
SRF, Elk-1, CREB, and ATF1, bound on the 
serum response element (SRE) and the cAMP 
response elements (CREs) of the c-fos 
enhancer/promoter (2,3). The activators 
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promote formation of the preinitiation 
complex, which consists of general 
transcription factors (TFIIA, TFIIB, TFIID, 
TFIIE, TFIIF, and TFIIH) and RNAPII, and 
also facilitate the subsequent steps of 
transcription (4). This activation process is 
believed to require physical and functional 
interactions among activators, the basal 
transcriptional machinery, and a third class of 
factors termed coactivators or coregulators 
(5). 
  Several factors have been proposed to 
serve as coactivators for the activators bound 
on the c-fos gene. For instance, p300/CBP 
functions as a bridging factor, a scaffold and 
a histone acetyltransferase for SRF, Elk-1 and 
CREB, integrating multiple signals to 
regulate their target genes (6). The Med23 
subunit of Mediator, originally identified as 
an E1A-interacting protein, interacts with 
Elk-1 and is required for activating 
transcription of SRE-containing genes such 
as egr-1 and c-fos (7,8). A family of potent 
coactivators, transducers of regulated CREB 
activity (TORCs), bind the DNA-binding 
domain of CREB and facilitate the 
interaction between CREB and TAF4, 
enhancing transcription of CRE-containing 
genes regardless of the phosphorylation 
status of CREB (9). In addition to these 
coactivators, we previously reported a 
coactivator-like activity termed 
transcriptional regulator of c-fos (TREF), 
which stimulates transcription from the c-fos 
promoter in vitro. One component of the 
TREF activity was identified as hnRNP R 
(10), an RNA-binding protein that can 
potentially interact with various RNAs, 
raising the possibility that hnRNP R serves as 
a coactivator for the c-fos gene through a 
novel mechanism that differs from those of 
p300/CBP, TORCs, and Mediator. 
  To further clarify the molecular identity of 
the TREF activities, we purified another 
component of TREF and identified it as the 
complex of NF45 and NF90. NF90 and its 
splicing variant NF110 contain 
double-stranded RNA binding motifs 
(dsRBMs), which have been demonstrated 
experimentally to bind dsRNAs (11-13). 
Consistently, NF90 binds the AREs present in 
a number of mRNAs to regulate the stability, 
nuclear export, and cellular distribution 
(14-22) of these mRNAs; moreover, NF90 is 
also known to modulate the rate of translation 
(17,20,23). NF90 and NF110 bind to 
genomic RNAs of various viruses and are not 
only involved in cellular defense against viral 
infection but also utilized as host factors for 
viral replication (24,25). In addition to the 
functions involving their dsRNA-binding 
activities, NF90 and NF110 have been 
implicated in regulating transcription. Indeed, 
several studies suggested that the 
NF45-NF90 complex binds specific DNA 
sequences (26-29) and activates transcription 
in cell-based assays (30-35). Given the role 
for the NF complexes in mRNA stabilization, 
however, it has been unresolved if the NF 
complexes have a direct transcriptional 
function to increase mRNA levels. 
  Using a highly purified in vitro 
transcription system, we show that the NF 
complexes have a direct transcriptional 
function as a coactivator. This coactivator 
activity does not require dsRNA-binding 
activities, which are essential for the mRNA 
stabilizing activity of the NF complexes. 
Knockdown of the endogenous NF90/NF110 
in mouse cells shows that the NF complexes 
play an important role in rapid induction of 
c-fos transcription. The NF complexes are 
present on the c-fos enhancer/promoter 
region before serum induction, and their 
occupancies within the coding region 
increase in parallel to that of RNAPII upon 
serum induction. Consistent with their 
occupancy on the c-fos enhancer/promoter 
and their role as a coactivator, the NF 
complexes interact with the activators and the 
general transcriptional machinery. Given 
their dynamic occupancy on the c-fos gene 
and well-known functions in 
posttranscriptional processes, the NF 
complexes may coordinate multiple steps in 
gene expression by dynamically associating 
with diverse machineries that regulate gene 
expression. 
 
EXPERIMENTAL PROCEDURES 
 
  Plasmids─Based on the published DNA 
sequences (33), the coding regions of human 
NF45, NF90, and NF110 were amplified 
from HeLa cell mRNA using a PCR-based 
method (10). The cDNA clones were tagged 
with the triple (3x) FLAG at their C-termini 
by PCR and then subcloned into pVL1392 
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(BD Biosciences) for baculovirus expression 
or pcDNA3 (Invitrogen) for transient 
expression in mammalian cells. The cDNAs 
encoding NF45, NF90, and NF110 tagged 
with GST at their N termini were created by a 
PCR-based method and subcloned into 
pVL1392. The baculovirus vector for 
expressing firefly luciferase was created by 
using the cDNA amplified from pGL3-basic 
vector (Promega). PCR-based mutagenesis 
was used to create the cDNAs encoding 
NF90(FA) and NF110(FA) by mutating F432 
and F559 into alanine, and those encoding 
NF90(AP) and NF110(AP) by mutating A458 
and A588 into proline. The cDNAs of general 
transcription factors were tagged 
N-terminally with the FLAG epitope using 
corresponding cDNAs (36) and the derived 
cDNAs were subcloned into pVL1392. 
RNGTT, Oct-1, and USF were similarly 
tagged with the FLAG epitope using cDNAs 
amplified by PCR using HeLa cell mRNA 
and subcloned into pVL1392. All the cDNA 
clones were sequenced entirely to exclude 
PCR-derived errors. The vectors for 
expressing FLAG-tagged SRF, Elk-1, CREB, 
and ATF1 are described previously (10). 
  Protein Purification─Baculovirus transfer 
vectors were cotransfected into Sf9 cells with 
linearized baculoviral DNA (BD 
Biosciences) to produce the recombinant 
viruses, which were used for infecting High 
Five cells. The cell extracts were prepared 
essentially as described (10). For expressing 
the complexes of NF45-NF90 and 
NF45-NF110, High Five cells were 
coinfected with two different baculoviruses 
expressing each subunit. All the purification 
procedures used BC buffer, which consists of 
20 mM Hepes-KOH, pH 7.9, 1 mM EDTA, 
and 10% glycerol, with the number in the 
parenthesis indicating the concentration 
(mM) of KCl. The extract was loaded onto a 
HiTrap Q column equilibrated with BC(100) 
containing 0.5 mM PMSF and 1 mM DTT, 
and the bound proteins were eluted in a linear 
gradient from 0.1 M KCl to 1.0 M KCl. The 
NF45, NF90, NF110, and their complexes 
were eluted at 300-500 mM KCl. The 
fractions containing the NF proteins were 
then subjected to a Sephacryl S300 gel 
filtration column (GE Healthcare) in BC(500) 
containing 0.5 mM PMSF. Because all the 
NF proteins contained a 3xFLAG tag, 
appropriate fractions were bound to 
anti-FLAG M2 agarose (SIGMA-Aldrich) in 
BC(300) containing 1 mM PMSF and 0.01% 
Triton X-100, and the bound proteins were 
eluted in the same buffer containing 0.1 
mg/ml 3xFLAG peptide. Extracts for general 
transcription factors were prepared similarly. 
For GST pulldown assays, the extract was 
purified partially on a HiTrap Q column to 
remove nucleic acids. Extracts for GST 
fusion proteins were prepared similarly and 
used directly for binding the fusion proteins 
to Glutathione Sepharose 4B (GE Healthcare). 
Purification of the transcription factors used 
for in vitro transcription was performed as 
described (10). 
  Antibodies─ The cDNAs encoding the 
C-terminal regions of NF45 (residues 
162-390), NF90 (residues 353-706), and 
NF110 (residues 725-898) were amplified 
and subcloned into pET15b, and the resultant 
plasmids were transformed into 
BL21(DE3)pLysS. The recombinant proteins, 
induced by 1 mM IPTG, were separated by 
preparative SDS-PAGE, and after excision of 
the appropriate portion of the gel, the 
proteins were eluted using the Model 422 
electro-eluter (Bio-Rad Laboratories). The 
purified proteins were then used to immunize 
rabbits to obtain anti-sera. The crude antisera 
were purified through columns in which the 
C-terminal regions of NF45, NF90, and 
NF110 were crosslinked to Sepharose 4B by 
dimethyl pimelimidate (Pierce). The bound 
antibodies were eluted in 0.2 M glycine-HCl, 
pH 2.5 and dialyzed against 
phosphate-buffered saline. The anti-RPB2 
antibody was prepared in essentially the same 
manner, using the residues 1-306 of RPB2 as 
purified antigen. 
  In Vitro Transcription ─ In vitro 
transcription assays were performed 
essentially as described previously, using the 
templates containing the c-fos promoter, 
pfMC2AT, and five GAL4-binding sites, 
pG5HMC2AT (10,37). To allow the inclusion 
of additional factors in the reactions, however, 
the volume of transcription assays was 
increased to 50 µl instead of 25 µl. 
  Chromatin Immunoprecipitation (ChIP) 
Assays─ ChIP assays were performed as 
previously described (38) with some 
modifications. To avoid inactivating anti-NF 
antibodies, 1% SDS in the lysis buffer and 
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the ChIP dilution buffer and 0.1% SDS in 
Low Salt Buffer and High Salt Buffer were 
substituted by 1% and 0.1% Nonidet P-40, 
respectively; moreover, 1% deoxycholate in 
LiCl Buffer was omitted. C3H10T1/2 cells, 
grown in a 100-mm culture dish, were 
starved in DMEM containing 0.5% fetal 
bovine serum (FBS) for 24 h and then 
stimulated by the addition of 20% FBS for 30 
or 60 min. Then, the cells were fixed, 
collected after wash, and suspended in 150 µl 
of the lysis buffer containing Protease 
Inhibitor Cocktail (SIGMA-ALDRICH). The 
soluble extract, prepared by sonication, was 
diluted and used for immunoprecipitation, in 
which antigen-purified anti-NF45, 
NF90/NF110, NF110, and RPB2 antibodies 
as well as non-immune rabbit IgG 
(SIGMA-ALDRICH) were mixed with the 
diluted extract. After the addition of 
recombinant Protein A Sepharose CL-4B (GE 
Healthcare), the mixture was rotated for 1 h. 
The mixture was then washed successively in 
Low Salt Buffer, High Salt Buffer, LiCl 
buffer, and TE Buffer, and DNA was isolated 
for quantitative PCR analyses. The primers 
used for quantitative PCR were as follows. 
5’-GACTGAAACGCTATTTCACTGTAC-3’ 
and 
5’-TCCCACCACTACAAAACCTGAGAG-
3’ for the –3,400 region, 
5’-CCAACCTCAGTCCTAAAGTTTCTC-3’ 
and 
5’-GGTCATTGTCCAGCAATCTGGAAC-3’ 
for the –600 region, 
5’-GCGAGCTGTTCCCGTCAATCCCTC-3’ 
and 
5’-AGACCTTCCGCGTGTAGGATTTCG-3’ 
for the –300 region, 
5’-TTGAAAGCCTGGGGCGTAGAGTTG-
3’ and 
5’-GGCTCTATCCAGTCTTCTCAGTTG-3’ 
for the transcription start site, 
5’-GGTTAGAAAAACTGCTTCACCGAG-
3’ and 
5’-TTTCTCTTCCTCTTCAGGAGATAG-3’ 
for the +1,600 region, and 
5’-ATTAACCTGGTGCTGGATTGTATC-3’ 
and 
5’-ATTGACGCTGAAGGACTACAGTAC-3’ 
for the +3,000 region, 
5’-TCCTAAGCCAGTGAGTGGCACAGC-
3’ and 
5’-ACACAACTATGTCAGAAGCAAATG-3’ 
for the transcription start site of the  
β-globin gene, and 
5’-ACCCTTGGACCCAGCGGTACTTTG-3’ 
and 
5’-AAGGTGCCCTTGAGGCTGTCCAAG-
3’ for the +400 region of the β-globin gene. 
For PCR reactions, Power SYBR Green PCR 
master mix and ABI PRISM 7900HT 
Sequence Detection System (Applied 
Biosystems) were utilized. 
  GST Pulldown Assays ─ GST-fusion 
proteins were expressed by infecting insect 
cells with appropriate baculoviruses. When 
expressing GST-fused NF45-NF90 or 
NF45-NF110, the cells were co-infected with 
the baculovirus expressing GST-NF45 and 
that expressing either NF90 or NF110. 
GST-VP16 was expressed in E. coli as 
described (37). GST pulldown assays for 
purified proteins, the TREF fraction, or HeLa 
nuclear extract, were performed essentially as 
described (38), except that the bound proteins 
were eluted from the Sepharose beads 
prebound with GST-activators using an equal 
volume of BC(1000) containing 0.5 mM 
PMSF and 1 mM DTT. 
  RNA Interference (RNAi)Assays─~5 x 105 
C3H10T1/2 cells in a 35-mm culture dish 
were transfected with Stealth RNAiTM siRNA 
for NF90/NF110 (Invitrogen, MSS205464) 
or a negative control duplex (Invitrogen, 
medium GC duplex) using LipofectamineTM 
2000 (Invitrogen), and then the cells were 
cultured in fresh DMEM containing 10% 
FBS for 48 h to knockdown NF90/NF110 
expression before cell lysates were prepared. 
To induce c-fos transcription, the 
siRNA-transfected cells were starved in 
DMEM containing 0.5% FBS for 24 h before 
the addition of the medium containing 20% 
FBS, 25 ng/ml of anisomycin, or 5 ng/ml of 
EGF. The cells were then collected at 
indicated time points to prepare total cellular 
RNAs and cell lysates. The efficiency of the 
NF90/NF110 knockdown was estimated by 
immunoblots of the cell lysates with 
antibodies against NF90/NF110. The isolated 
total cellular RNAs were used for measuring 
the amount of the c-fos mRNA by 
quantitative RT-PCR. The primers for 
amplifying the c-fos mRNA were 
5’-GAGGACCTTACCTGTTCGTGAAA-3’ 
and 5’-CCAGATGTGGATGCTTGCAA-3’. 
The primers for the α-tubulin RNA were 
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5’-GGTTCCCAAAGATGTCAATGCT-3’ 
and 
5’-CAAACTGGATGGTACGCTTGGT-3’. 
The amounts of the α-tubulin mRNA, which 
were essentially invariable under the tested 
conditions, were used for normalization. 
  Cell Transfection and Reporter Assays─
3.3 x 104 HEK293 cells in a 48-well plate 
were transfected with 356 ng of plasmid 
DNA using LipofectamineTM 2000 
(Invitrogen), and the cells were washed and 
then lysed. The lysates were used for 
assaying the luciferase and β-galactosidase 
activities according to the manufacturer’s 
instructions (Promega). Each experiment was 
performed at least 3 times, and the values of 
the luciferase activities were normalized with 
those of β-galactosidase activities. 
 
RESULTS 
 
  The NF45-NF90 Complex is a Component 
of the TREF Activity ─ To identify the 
molecular component(s) of the TREF activity, 
we purified the TREF fraction derived from 
HeLa nuclear extracts (Fig. 1A), by 
monitoring its coactivator activity using the 
c-fos template, pfMC2AT (10). The 
purification through four different columns 
revealed that TREF could be separated into 3 
distinct activities termed TREFα, TREFβ and 
TREFγ (Fig.1A). TREFα was identified as 
hnRNP R, an RNA-binding protein that 
possesses three RNA recognition motifs 
(RRMs) and an arginine-glycine-glycine rich 
(RGG) box (10). In this study, we purified 
TREFγ to near homogeneity, and its peak 
fractions revealed two major polypeptides, 
which were identified as NF45 and NF90 by 
mass spectrometric analyses (Fig. 1, A and B). 
To obtain direct evidence of the 
transcriptional activity of NF45 and NF90, 
FLAG-tagged NF45 and NF90 were 
co-expressed in insect cells and purified to 
near homogeneity (Fig. 1E). Because NF45 
and NF90 interact with each other to form a 
stable complex, we will hereafter refer to 
their complex as NF45-NF90. Recombinant 
NF45-NF90 stimulated transcription from the 
c-fos promoter in a dose-dependent manner 
and to a similar but slightly lesser extent as 
compared to native TREFγ (Fig. 1F), 
eliciting a ~5-fold stimulation over the 
activator-dependent c-fos transcription (lanes 
2 and 6). 
  The gene for NF90 also encodes an 
alternatively spliced mRNA, which is 
translated into NF110 that diverges from 
NF90 at the C-terminal region (Fig. 1B) 
(33,39). Because silver-stained SDS-PAGE 
gel of the TREFγ fraction revealed a 
substoichiometric amount of ~110 kDa 
protein (Fig. 1A, arrowhead) that reacted 
with an anti-NF90/110 antibody (Fig. 1, C 
and D), we tested if NF45-NF110 possesses 
the TREFγ activity as well. Recombinant 
NF45-NF110, prepared similarly by the 
baculovirus system (Fig. 1E), stimulated 
transcription from the c-fos promoter as in 
the case of NF45-NF90 (Fig. 1G). 
Dose-response experiments (Fig. 1G) showed 
that NF45-NF110 enhanced transcription 
slightly better than NF45-NF90 in the 
presence (lanes 2, 4, 6, 8, and 10) or absence 
(lanes 1, 3, 5, 7, and 9) of the activators. 
These results show that both NF45-NF90 and 
NF45-NF110 function as a coactivator for 
transcription from the c-fos promoter in vitro. 
 
  The Transcriptional Activities of the NF 
Complexes Vary on Different Promoters─
Because TREF stimulates transcription from 
the c-fos promoter but has little stimulatory 
activity towards GAL4-VP16-dependent 
transcription (10), we tested if the NF 
complexes display a selective activity 
towards the c-fos promoter as well. As shown 
in Fig. 2A, in vitro transcription assays 
showed that 30 ng and 90 ng of NF45-NF90 
stimulated activator-dependent transcription 
from the c-fos promoter by 1.5- and 4.5-fold 
over that in the absence of NF45-NF90 
(compare lane 2 versus lanes 4 and 6). In 
contrast, NF45-NF90 stimulated 
GAL4-VP16-denpedent transcription by 2.1- 
and 1.9-fold under the same condition (Fig. 
2A, compare lane 8 versus lanes 10 and 12). 
Thus, although TREF does not stimulate 
transcription from the 5xG promoter at all 
(10), NF45-NF90 does do so, albeit to a 
lesser extent than the c-fos promoter, 
indicating that some components in TREF 
other than NF45-NF90 may repress 
transcription from the 5xG promoter. In 
cell-based assays using the c-fos promoter 
fused to the luciferase gene, NF45-NF90 and 
NF45-NF110 stimulated c-fos transcription 
by ~3.5-fold (Fig. 2B). Using the same assays, 
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we found that other promoters were also 
stimulated by both NF45-NF90 and 
NF45-NF110 to different extents (2-5-fold) 
(Fig. 2C). In contrast, the 5xG promoter 
fused to the luciferase gene was stimulated 
by less than 2-fold (Fig. 2B). These in vitro 
and in vivo studies indicate that the 
coactivator activities of NF45-NF90 and 
NF45-NF110 are less effective towards 
GAL4-VP16-dependent transcription than 
c-fos transcription and that their 
transcriptional effects vary among different 
promoters. 
 
  The NF Complexes Cooperate with PC4 
and Mediator─We also tested if NF45-NF90 
cooperates with PC4 and Mediator to 
stimulate c-fos transcription in vitro, as 
observed for TREF (10). When NF45-NF90, 
PC4, and Mediator were tested individually, 
each coactivator stimulated 
activator-dependent transcription from the 
c-fos promoter by 3-7-fold, with the strongest 
stimulation displayed by PC4 (Fig. 2D, 
compare lane 2 versus lanes 3-5). 
NF45-NF90 showed a somewhat weaker 
activity than PC4, yet it had a stronger 
activity than Mediator (Fig. 2D, lanes 3-5). 
Though their individual transcriptional 
stimulation was moderate, combined effects 
by two of the coactivators were more 
pronounced (Fig. 2D, lanes 6-8), indicating 
that they cooperate with each other to 
stimulate c-fos transcription. Indeed, when all 
three coactivators were included 
simultaneously in the reaction (Fig. 2D, lane 
9), the level of c-fos transcription increased 
by 54-fold over that in the absence of any 
coactivator (compare lane 2 versus lane 9) 
and by 543-fold over its basal level in the 
absence of activators and coactivators 
(compare lane 1 versus lane 9). These results 
demonstrate that both NF45-NF90 and 
NF45-NF110 cooperate with PC4 and 
Mediator to stimulate c-fos transcription in 
vitro. 
 
  Double-stranded RNA-binding Activity is 
Dispensable for the Coactivator Activity of 
the NF Complexes in Vitro─Previous in vivo 
studies showed that the dsRNA-binding 
activity of NF110 is important for increasing 
the expression of the reporter gene in 
cell-based assays (31). In these assays, 
however, the increased expression could be 
caused by the mRNA stabilization by NF90 
and NF110 (14,16,17,19). Moreover, NF110, 
which has a weaker dsRNA-binding activity 
than NF90, showed a stronger effect on gene 
expression than NF90 in similar cell-based 
assays (31,33). To clarify the relationship 
between dsRNA-binding and transcriptional 
activities of the NF complexes, we created 
NF90(FA), in which two phenylalanine 
residues, F432 and F559, were mutated into 
alanine and NF90(AP), in which two alanine 
residues, A458 and A588, were mutated into 
proline as well as the corresponding NF110 
mutants described previously (31). As 
expected, NF90(FA), NF90(AP), NF110(FA), 
and NF110(AP) showed virtually no binding 
to 32P-labeled poly(I)·poly(C) in northwestern 
assays (Fig. 3A). When introduced into 
C3H10T1/2 cells together with NF45, the 
dsRBM mutants, especially NF90(AP) and 
NF110(AP), showed lower levels of the 
reporter gene expression than their wild-type 
counterparts (Fig. 3B), in essential agreement 
with the previous study (31). 
  However, when these mutants were tested 
directly in in vitro transcription assays, in 
which there is no post-transcriptional effect, 
NF45-NF90(FA), NF45-NF90(AP), 
NF45-NF110(FA), and NF45-NF110(AP) 
stimulated transcription from the c-fos 
promoter to the levels comparable to those of 
their wild-type counterparts (Fig. 3C), 
indicating that the intact dsRBMs are 
dispensable for the direct coactivator activity 
of the NF complexes observed in vitro. We 
also tested the effect of RNA on the 
coactivator activities of the NF complexes by 
including poly(I)·poly(C) or total cellular 
RNA. Increasing the amounts of 
poly(I)·poly(C) (Fig. 3D) or total cellular 
RNA (Fig. 3E) did not augment the 
coactivator activities of the NF complexes 
but instead gradually repressed the levels of 
transcription (Fig. 3D). This repressive effect 
of poly(I)·poly(C) (Fig. 3D) and total cellular 
RNA (Fig. 3E) is unrelated to the 
dsRNA-binding activity of the NF complexes 
because the repression was also observed 
regardless of their dsRNA-binding activities. 
Thus, although there remains a possibility 
that some specific RNAs such as small 
NF90-associated RNAs (40) regulate the 
activities of the NF complexes via their 
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dsRBMs, these results indicate that the NF 
complexes possess a coactivator activity that 
is independent of their dsRNA-binding 
activity. 
 
  NF90 and NF110 are Important for Rapid 
Induction of c-fos Transcription─Next, to 
obtain the in vivo evidence that NF45-NF90 
and NF45-NF110 are required for c-fos 
transcription, we knocked down the 
endogenous NF90/NF110 and analyzed the 
level of c-fos transcription. When 
C3H10T1/2 cells were transfected with 
siRNA specific for the mouse NF90/NF110 
gene, the amounts of NF90 and NF110 
decreased to undetectable levels whereas 
control siRNA did not have any effect (Fig. 
4A). We then analyzed induction of the c-fos 
mRNA in cells stimulated with 20% fetal 
bovine serum after 24-hr serum starvation. 
Fig.4B shows that the knockdown reduced 
the level of the c-fos mRNA, especially 
during 15-30 min after serum stimulation and 
that the level of the c-fos mRNA returned 
virtually to that in the control cells after 90 
min. Because serum may contain various 
stimuli that can induce c-fos transcription, we 
tested two well-defined stimuli, anisomycin 
and EGF, whose effects are mediated by the 
JNK/p38 and Erk1/2 subfamilies of MAP 
kinases, respectively. As shown in Fig. 4C, 
RNAi knockdown of NF90/NF110 had no 
significant effect on anisomycin-induced 
c-fos transcription. By contrast, EGF 
induction of the c-fos gene was markedly 
reduced upon NF90/NF110 knockdown (Fig. 
4D). In all the RNAi knockdown experiments, 
the levels of the α-tubulin mRNA remained 
comparable in cells treated with control or 
NF90/NF110-specific siRNA (Fig. 4, E-G). 
Thus, NF90 and NF110 play an important 
role in rapidly inducing c-fos transcription, 
especially in response to serum or EGF 
stimulation. 
 
  The NF Complexes Dynamically Occupy 
the c-fos Gene─In view of the multiple roles 
for the NF complexes in transcription (Fig. 4) 
and posttranscriptional processes (39,41), we 
wished to know the temporal occupancy of 
NF45, NF90, and NF110 on the c-fos gene 
during its transcriptional induction. 
C3H10T1/2 cells were starved and then 
treated with 20% FBS for 0 min, 30 min, and 
60 min before the cells were fixed with 
formaldehyde, and the chromatin was 
immunoprecipitated by anti-NF45, 
anti-NF90/NF110, or anti-NF110 antibodies 
(Fig. 1C). The precipitated DNA was then 
used for quantitative PCR with sets of 
primers designed to amplify ~100-bp regions 
around –3,400, –600, –300, +1, +1,600, and 
+3,000 of the c-fos gene (Fig. 5A). In 
addition, sets of primers for the +1 and +400 
regions of the β-globin gene, which is not 
expressed in C3H10T1/2 cells, were used as 
controls. 
  Under the starved condition (0 min), the 
NF proteins were present from the upstream 
regions (–600 and –300) to the transcription 
start site (+1) whereas much less amounts of 
the NF proteins were observed in the far 
upstream region (–3,400) and the 
downstream regions (+1,600 and +3,000) 
within the c-fos gene (Fig. 5B). RNAPII also 
showed a similar occupancy to those of the 
NF proteins. As expected, 30 min after serum 
addition when the c-fos gene is induced 
maximally, the RNAPII occupancy increased 
dramatically at the start site (+1) and in the 
downstream regions (+1,600 and +3,000) of 
the c-fos gene. Concomitantly, the 
occupancies of the NF proteins increased in a 
similar manner to that of RNAPII in the 
coding regions (+1,600 and +3,000), raising 
the possibility of some physical association 
between RNAPII and the NF proteins. 
Whereas the occupancies of the NF proteins 
remained largely unchanged in the upstream 
regions (–600 and –300) and at the start site 
(+1), slight reductions in the occupancies of 
NF90 and NF110 were observed in the –300 
and +1 regions, which could possibly reflect 
transfer of the NF proteins from the promoter 
to the elongating RNAPII. After 60 min, the 
occupancies of the NF proteins and RNAPII 
returned rapidly to the pre-induction levels. 
As control, no significant occupancies of the 
NF proteins and RNAPII were observed on 
the β-globin gene in C3H10T1/2 cells. 
  These experiments demonstrate that the 
NF proteins are associated with the 
regulatory and core promoter regions of the 
c-fos gene before induction and that the 
occupancies of the NF proteins undergo 
dynamic changes during induction of c-fos 
transcription. These results suggest that the 
NF proteins, probably as the complexes of 
NF45-NF90 and NF45-NF110 function as transcriptional coactivators 
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NF45-NF90 and NF45-NF110, may travel 
along the gene with elongating RNAPIIs, 
further substantiating their dual roles in 
transcription and posttranscriptional 
processes. 
 
  NF45-NF90 and NF45-NF110 Stimulate 
Transcription Through Both the Upstream 
Regulatory Elements and the Core Promoter
─Our in vitro analyses indicated that the NF 
proteins stimulate both activator-dependent 
and basal transcription (Figs. 1 and 2). In 
addition, we observed a marked occupancy of 
the NF proteins on the c-fos gene from the 
–600 to +1 region (Fig. 5), which 
encompasses from the upstream regulatory 
elements to the core promoter. Thus, to 
delineate the c-fos promoter region that 
mediates the transcriptional activity of the 
NF proteins, we tested a series of deletion 
mutants of the c-fos regulatory elements (Fig. 
6A). Deletion of the upstream region from 
–733 to –500 did not affect the luciferase 
activity at all. However, further deletion from 
–500 to –55, including the known regulatory 
elements (SRE, FAP-1, and CRE), reduced 
the level of the luciferase activity 
dramatically regardless of the presence of the 
NF complexes, in accord with the critical 
roles of these elements in c-fos transcription. 
Importantly, the 2.5-3.0-fold stimulation by 
NF45-NF90 or NF45-NF110 observed for the 
c-fos promoter (from –733 to +158) 
decreased gradually as the region 
downstream from –500 were removed 
progressively. These results indicate that the 
NF complexes act broadly through the 
regulatory elements between –500 and –55, 
the region that conform approximately with 
the occupancy of the NF proteins on the 
endogenous c-fos gene (Fig. 5). Moreover, 
introduction of point mutations into the 
individual regulatory elements (SRE, FAP-1, 
and CRE) also decreased the luciferase 
activity, while still allowing a ~1.8-fold 
stimulation in the presence of NF45-NF90 
and NF45-NF110 (Fig. 6B). Finally, the 
reporter gene with only the core promoter 
(–55 to +158) was stimulated ~1.8-fold by 
NF45-NF110 but not by NF45-NF90, 
indicating that NF45-NF110 has a direct 
stimulatory effect on the core promoter as 
well. These results indicate that the NF 
complexes stimulate c-fos transcription 
through both the upstream regulatory 
elements and the core promoter, in agreement 
with the occupancies of the c-fos 
enhancer/promoter region by the NF proteins 
in cells. 
 
  Multiple interactions of the NF proteins 
with activators and the basal transcriptional 
machinery─The coactivator function of the 
NF complexes and their occupancy on the 
c-fos gene on its enhancer/promoter region 
suggested that they might interact directly 
with activators and the basal transcriptional 
machinery. We therefore expressed and 
purified recombinant FLAG-tagged NF 
proteins and their complexes (NF45-NF90 
and NF45-NF110), as well as the firefly 
luciferase protein for a control. The tagged 
proteins were then allowed to interact with 
various GST-fused activators pre-bound to 
Glutathione-Sepharose beads, and the bound 
proteins were eluted and analyzed by 
immunoblotting with anti-FLAG M2 
antibody. As shown in Fig. 7A, NF45-NF90 
and NF45-NF110 interacted with CREB, 
Elk-1, ATF1, and USF to varying degrees, 
and NF45-NF90 interacted with Oct-1. The 
observed interactions are specific because the 
luciferase protein did not interact with any 
activators, and none of the NF proteins or 
their complexes interacted with GST alone 
(Fig. 7A). Consistent with its role as a 
functional regulator of NF90 (32), NF45 
appeared to modulate the interactions of 
NF90 and NF110 with the activators although 
NF45 did not interact with any activators by 
itself. For instance, NF45 enhanced the 
interaction between NF90 and Oct-1 whereas 
it diminished the interaction between NF110 
and ATF1 (Fig. 7A). Finally, the NF proteins 
showed very weak interactions with the 
VP16 activation domain, which agrees with 
their minimal stimulatory activity toward 
GAL4-VP16-dependent transcription (Fig. 2, 
A and B).  
  As these assays were performed with 
purified proteins, we further examined the 
specificity by testing if the activators interact 
with the NF complexes in the extracts. 
Instead of purified NF complexes, we first 
incubated the TREF fraction (Fig. 1A) with 
GST-fused activators bound to 
Glutathione-Sepharose beads. After washing, 
the bound proteins, which corresponded to 
NF45-NF90 and NF45-NF110 function as transcriptional coactivators 
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1.9-2.3% of the proteins contained in the 
TREF fraction (data not shown), were tested 
for the presence of the NF complexes by 
immunoblots using anti-NF90/NF110 or 
anti-NF45 antibodies. As shown in the left 
panel of Fig. 7B, the bound fractions 
contained the NF complexes. We then used 
HeLa nuclear extract to perform the same 
experiments, and 1.0-1.5% of the proteins 
were bound to GST-fused activators (data not 
shown). Similar to the results with the TREF 
fraction, the NF complexes were detected in 
the bound fractions (Fig. 7B, right panel). 
These results show that the NF complexes 
interact specifically with the activators, albeit 
to different degrees. 
  Next, we tested the interactions between 
the NF proteins and the components of the 
basal transcriptional machinery. Because we 
wished to test if the NF proteins interact with 
multi-protein complexes including TFIID and 
TFIIH, we prepared NF45, NF90 and NF110 
as well as their complexes (NF45-NF90 and 
NF45-NF110) as GST-fusion proteins. In 
NF45-NF90 and NF45-NF110, only NF45 
was expressed as a GST-fusion protein, 
which formed heterodimers with non-tagged 
NF90 or NF110. As shown in Fig. 7C, the NF 
proteins showed interactions with TFIIB, 
TFIID, and TFIIH, but not with TFIIA, TFIIE, 
and TFIIF. Although NF45 did not interact 
with any activators (Fig. 7A), it interacted 
with TFIID and TFIIH as efficiently as did its 
heterodimeric partners, NF90 and NF110 
(Fig. 7C). NF45 reduced the interaction of 
NF90 with TFIIB, again indicating a possible 
regulatory role for NF45 in the context of the 
NF complexes. Collectively, the NF proteins 
have multiple interactions with both 
activators and the basal transcriptional 
machinery, in agreement with their direct 
transcriptional function and their occupancies 
on both the upstream regulatory elements and 
the core promoter (Figs. 1, 2, and 5). 
  Finally, despite the similar dynamic 
occupancies of RNAPII and the NF proteins 
on the c-fos gene (Fig. 5), neither individual 
NF proteins (NF45, NF90, and NF110) nor 
their complexes (NF45-NF90 and 
NF45-NF110) showed any interaction with 
RNAPII under the condition where the 
capping enzyme, RNGTT, bound specifically 
to the phosphorylated IIO (Fig. 7D). This 
result suggests that interactions between the 
NF complexes and RNAPII, if any, are likely 
to be indirect. 
 
DISCUSSION 
 
  The NF Complexes are Multifunctional 
Coactivators─In this study, we have purified 
TREFγ and ascribed its activity to the NF 
complexes, which consist of either NF45 and 
NF90 or NF45 and NF110 (39). The NF 
complexes were identified initially as a 
DNA-binding factor that binds the ARRE site 
(26,27), the CCAAT binding site (28) and an 
MHC-I site (29). However, independent 
studies identified the NF proteins by means 
of their RNA-binding activity and named 
them as ILF3 (42), DRBP76 (13) or TCP80 
(23). Indeed, NF90 and NF110 possess two 
dsRBMs, which, as the name implies, is a 
modular nucleic acid binding motif that binds 
duplexed RNA but not ssRNA, dsDNA or 
ssDNA (11-13). Consistent with the presence 
of dsRBMs, the NF complexes do not bind 
dsDNA under the conditions where their 
binding to dsRNA can be demonstrated 
unambiguously (33,43,44). Given the 
absence of any consensus DNA sequence 
among the presumptive NF-binding DNA 
elements described above (26-29), it 
remained to be defined if the NF complexes 
regulate transcription by binding directly to 
specific DNA sequences (45). Further 
complicating their role in transcription is that 
the NF complexes stabilize mRNA through 
binding to specific RNA sequences (14,19). 
Thus, the transcriptional stimulation by the 
NF complexes observed in cell-based assays 
may be attributed to posttranscriptional 
effects (39,41). Thus, despite the several 
reports that the NF complexes increase the 
level of mRNA in vivo (30-35), it has been 
unclear whether they have a direct function in 
transcription. 
  Combined with in vitro transcription 
assays, our unbiased identification and 
purification of the TREFγ activity from cell 
extract demonstrate, beyond the presumed 
role in transcription by earlier studies, that 
the NF complexes possess a direct function in 
transcription from the c-fos promoter. Earlier 
(31) as well as our own studies (Fig. 3B) 
using cell-based assays show that the 
mutations of dsRBMs drastically diminish 
the ability of the NF complexes to stimulate 
NF45-NF90 and NF45-NF110 function as transcriptional coactivators 
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transcription as measured by mRNA levels. 
However, the NF complexes stimulated 
transcription in vitro even when its dsRBMs 
were mutated (Fig. 3C), demonstrating that 
the NF complexes possess a direct 
transcriptional function that is separate from 
the posttranscriptional functions that require 
intact dsRBMs. Consistent with the direct 
transcriptional function, the NF proteins 
interact physically with the components of 
the basal transcriptional machinery, notably 
with TFIID and TFIIB that are pivotal in 
transcriptional regulation. Because the NF 
complexes exert the transcriptional effect 
through multiple cis-regulatory elements (Fig. 
6), probably by interacting with various 
activators (Fig. 7A), they are likely to 
function as a transcriptional coactivator. 
Given that knockdown of NF90/NF110 
attenuates the induction of c-fos transcription 
upon serum or EGF stimulation (Fig. 4D), 
together with their previously demonstrated 
roles in posttranscriptional processes (39,41), 
the NF complexes may coordinate 
transcription and post-transcriptional 
processes to elicit rapid response of inducible 
genes. 
  Coordination between transcription and 
posttranscriptional processes has been 
reported for numerous proteins (46,47). For 
example, PGC-1 and CoAA, initially 
identified as transcriptional coactivators, 
were later shown to function in 
posttranscriptional processes as well (48,49). 
PGC-1 possesses an RRM and an RS domain, 
both of which are RNA-binding domains that 
interact with splicing factors and are essential 
for coupling transcription and mRNA 
processing (48,50). Similarly, two RS 
domains in CoAA play a role in linking 
transcription and splicing in a 
promoter-preferential manner (50). 
Furthermore, another coactivator RHA 
possesses dsRBMs and an RGG domain 
(41,51), which are RNA-binding motifs also 
present in NF90 and NF110. Interestingly, 
RHA copurifies with NF45-NF90 through 
several column chromatographies and 
interacts directly with NF90 and NF110 
(11,33), suggesting a functional partnership 
between the NF complexes and RHA. On the 
whole, the prevalence of RNA-binding 
motifs in these coactivators suggests that the 
functional coordination between transcription 
and posttranscriptional processes may entail 
direct interactions between these 
RNA-binding coactivators and the RNA 
transcript emerging from RNAPII. 
  How the NF complexes participate in 
multiple aspects of RNA metabolism, 
however, remains to be elucidated. One 
possibility is that NF90 and NF110 have 
separate roles in distinct steps of gene 
expression; for example, NF110 may 
function at earlier steps than NF90 does. For 
instance, although NF110 and NF90 are 
distributed in both nucleus and cytoplasm 
(14,27,28,33,52), NF110 tends to be more 
abundant in nucleus whereas NF90 is more 
readily observed in cytoplasm. In addition, 
NF110 appears to stimulate gene expression 
slightly better than NF90 in vivo (31,33) and 
in vitro (Fig. 1G) ; by contrast, NF90, but not 
NF110, is implicated in mRNA export and 
stabilization (14,19). An alternative, but not 
mutually exclusive, possibility is that the NF 
complexes serve as a scaffold that assembles 
different proteins to acquire functions besides 
their intrinsic activities. Consistent with this, 
the NF proteins have been shown to interact 
with multiple proteins such as YY-1 (30,53), 
PKR (13,30,54,55), PRMT1 (11,33,53,56), 
RHA (11,33), SMN(30), and FUS (30) and 
have been isolated as a component of 
RNAPII-interacting proteins as well as an 
integral component of H complex (57,58). 
  Although we identified the NF complexes 
from their transcriptional activity on the c-fos 
promoter, our own data and those from others 
(26,32,33,35) indicate that the NF complexes 
stimulate transcription of other genes as well. 
In NF90(-/-) knockout mice, T cells show 
severely impaired expression of IL-2, which 
is regulated at multiple steps of gene 
expression by the NF complexes (59). 
Moreover, up regulation of NF90 in cancer 
cells increases mRNAs of 
interferon-regulated genes, which are also 
prototypical inducible genes (34). These 
observations make it highly likely that a 
subset of inducible genes require the NF 
complexes for their prompt expression, 
which requires coordination among the 
multiple steps from transcription to 
translation. 
 
  Dynamic Occupancy of the NF Complexes 
within the c-fos Gene─The NF complexes 
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have been shown to possess both NES and 
NLS, which permit shuttling between nucleus 
and cytoplasm (14,52,60,61). In a significant 
extension of the earlier studies that showed 
the occupancy of NF90 on the IL-2 gene (59) 
and their association with chromatin (33,62), 
our ChIP analyses revealed that the NF 
complexes are present on the intragenic and 
enhancer/promoter regions of the c-fos gene. 
Moreover, the occupancy of the NF proteins 
in the intragenic region parallels both 
temporally and spatially with that of RNAPII 
during c-fos induction (Fig. 5). This dynamic 
occupancy implies that the NF complexes 
move along the c-fos gene in association with 
transcribing RNAPII, which is entirely 
consistent with their dual roles in 
transcription and post-transcriptional 
processes (Fig. 8). 
  The dynamic occupancy along the c-fos 
gene raises the intriguing possibility that the 
NF complexes may act on the very same 
transcript whose transcription initiation they 
stimulated in the first place. This would 
explain why cell-based assays showed that 
the mutations of the dsRBMs drastically 
reduce the stimulatory effect of the NF 
complexes on transcription in vivo (Fig. 
3B)(31). Because the mutated dsRBMs can 
compromise the posttranscriptional effects of 
the NF complexes, their stimulatory effect on 
transcription initiation might have been 
largely cancelled out in the cell-based assays, 
giving a misleading impression that the 
transcriptional activity requires dsRNA 
binding. 
  The NF complexes may be recruited to the 
promoter region via direct interactions with 
the activators and/or the preinitiation 
complex (Fig. 8). NF90 and NF110 showed 
numerous interactions with the activators and 
the basal transcriptional machinery (Fig. 7), 
supporting the ChIP data that showed the 
occupancy of the NF complexes on the 
enhancer/promoter region (Fig. 5). Although 
the ChIP data also suggests that the NF 
complexes may be transferred from the 
promoter to the elongating RNAPII, if and 
how this occurs remains unclear. However, 
the transfer of the NF complexes may be 
critical for their functions. Indeed, when 
NF90 is tethered to the promoter region as 
Gal4-NF90, Gal4-NF90 appears to act like a 
dominant negative form and inhibits 
transcription (32), presumably because 
Gal4-NF90 cannot be transferred from the 
promoter region to the elongating RNAPII. 
  Given the parallel occupancies of the NF 
proteins and RNAPII, it was somewhat 
unexpected to find that the NF proteins do 
not interact directly with purified RNAPII, 
irrespective of the phosphorylation status of 
its CTD (Fig. 7D). Three lines of evidence, 
however, strongly indicate an indirect 
physical association between RNAP II and 
the NF complexes, probably mediated by 
their associated proteins and/or RNA 
transcript. First, a proteomic analysis 
revealed that the NF complexes are present in 
H complex together with hnRNPs and other 
types of RNA-binding proteins (63). H 
complex is believed to bind nascent RNA that 
has just emerged from RNAPII before the 
assembly of splicing factors (57,58). Second, 
the NF complexes are co-precipitated with 
the phosphorylated (and thus elongating) 
RNAPII and various RNA-binding proteins 
by an anti-CTD antibody (64). Third, the NF 
complexes are immunoprecipitated by an 
anti-Chd1 antibody, which also precipitates 
RNAPII and numerous proteins involved in 
splicing and other RNA processing steps (65). 
Interestingly, Chd1 binds the H3-K4me3 
(66,67), whose presence on the chromatin 
(68,69) overlaps with the occupancy of the 
NF complexes (Fig. 5). 
  In conclusion, this study reports that the 
NF complexes have a direct function in 
stimulating transcription as a coactivator. 
Given their roles in multiple steps of gene 
expression and the dynamic occupancy on 
the c-fos gene, it will be essential to elucidate 
the structure and function of the proteins that 
associate with the NF complexes during 
distinct steps of gene expression. 
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The abbreviations used are: 
GTF: general transcription factor 
TREF: transcriptional regulator of c-fos  
RNAP II: RNA polymerase II 
NF: nuclear factor 
hnRNP R: heterogeneous nuclear ribonucleoprotein R 
dsRBM: double-stranded RNA binding motif 
CRE: cAMP-responsive element 
CREB: CRE-binding protein 
SRE: serum response element 
PMSF: phenylmethylsulfonyl fluoride 
GST: glutathione S-transferase 
SRF: serum response factor 
Elk-1: Ets-related transcription factor 
ATF1: activating transcription factor 1 
FAP-1: c-fos AP-1 site 
TAF: TBP-associated factor 
PC4: positive cofactor 4 
RHA: RNA helicase A 
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LEGENDS TO FIGURES 
 
FIGURE 1. The NF complexes possess a direct transcriptional activity as coactivators. A, 
purification scheme of the TREF activities from HeLa cell nuclear extracts. The numbers 
indicate the molar concentration of KCl in the elution buffer. In a silver stained 
SDS-polyacrylamide gel of the purified TREFγ, the positions of NF45 and NF90 are indicated 
on the right and the arrowhead indicates the position of NF110. B, structures of NF45, NF90, 
and NF110. The number of amino acid residues is shown at the C terminus of each NF protein. 
RGG, DZF, NES, NLS, and dsRBM indicate arginine-glycine-glycine rich, dimerization zinc 
finger, nuclear export signal, nuclear localization signal, and double-stranded RNA-binding 
motif, respectively. The regions of the NF proteins used for immunizing rabbits are indicated by 
a black bar under the schematic structures of NF45, NF90, and NF110. Because 353-706 of 
NF90 is identical to 353-706 of NF110, the antibody raised against this region is designated as 
anti-NF90/NF110. C, NF45, NF90 and NF110 were separated by SDS-PAGE and stained with 
Coomassie Brilliant Blue (CBB). The antibodies were tested for their reactivity with NF45, 
NF90, and NF110. Anti-NF45, and anti-NF110 detected NF45 and NF110, respectively (WB). 
As expected, anti-NF90/NF110 detected both NF90 and NF110. D, the immunoblot with 
anti-NF110 (WB) revealed that the TREFγ fraction contained a small amount of NF110 as 
indicated by an arrowhead (left panel, silver staining). E, SDS-PAGE analysis of purified 
recombinant NF45-NF90 (lane 1) and NF45-NF110 (lane 2). F, Comparison of the 
transcriptional activities of TREFγ and NF45-NF90 using in vitro transcription of pfMC2AT. 
Activators indicate 20 ng of SRF, 10 ng of Elk-1, 20 ng of CREB, 20 ng of ATF1, and 200 ng of 
PC4 (lanes 2, 4, and 6). Semi-quantitative immunoblots with anti-NF45 antibody were used to 
estimate the amounts of the NF complexes in the TREFγ and recombinant NF45-NF90, and the 
reactions contained 6.7 µl of TREFγ (lanes 3 and 4) and 90 ng of NF45-NF90 (lanes 5 and 6), 
respectively. The arrow indicates the position of the transcript, and the relative levels of the 
transcripts are indicated below each lane. G, in vitro transcription reactions were performed as 
in F in the presence of the indicated amounts of NF45-NF90 and NF45-NF110. The relative 
transcription levels are indicated below each lane. 
 
FIGURE 2. The activity of the NF complexes on different promoters, and the functional 
cooperation among the NF complexes, PC4, and Mediator. A, transcription reactions 
contained SRF, Elk-1, CREB, ATF1, and PC4 (lanes 2, 4, and 6) for the c-fos template 
pfMC2AT (c-fos) as in Figure 1 D, and 25 ng of GAL4-VP16 and 200 ng of PC4 (lanes 8, 10, 
and 12) for pG5HMC2AT, which contains five GAL4-binding sites (5xG). The reactions 
included either 30 ng (lanes 3 and 4) or 90 ng (lanes 5 and 6) of NF45-NF90. The positions of 
the transcripts are indicated on the right and the relative levels of the transcripts are indicated 
below each lane. B, HEK293 cells were transfected with the indicated combinations of the 
plasmids expressing either NF45, NF90, and NF110, together with the luciferase gene fused to 
the c-fos promoter (left panel). The same sets of experiments were performed using the 
luciferase gene fused to the promoter containing five GAL4-binding sites and the plasmid 
expressing GAL4-VP16 (right panel). The relative levels of the luciferase activities are shown 
in each panel. The bars indicate standard error of the mean of three independent experiments. C, 
HEK293 cells were transfected with the luciferase reporter gene fused to the indicated 
promoters. The reporter genes were cotransfected with the empty expression vector (white bars), 
expression vectors for NF45 and NF90 (gray bars) or those for NF45 and NF110 (dark gray 
bars). The upper panel indicates the relative levels of the luciferase activities, and the lower 
panel indicates the fold activation by NF45-NF90 (gray bars) and NF45-NF110 (dark gray bars). 
The bars indicate standard error of the mean of three independent experiments. D, in vitro 
transcription assays contained the indicated combinations of 200 ng of PC4 (lanes 3, 6, 7, and 9), 
~30 ng of human Mediator (lanes 4, 6, 8, and 9), and 100 ng of NF45-NF90 (lanes 5, 7, 8, and 
9). The relative levels of transcript are shown below each lane. 
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FIGURE 3. The NF complexes do not require their dsRNA-binidng activities to function as 
a coactivator. A, partially purified NF proteins as well as control luciferase tagged with a FLAG 
epitope were separated by SDS-PAGE and detected by immunoblots using anti-FLAG M2 
antibody (upper panel). The same sets of proteins were tested for binding to 32P-labelled 
poly(I)·poly(C) (lower panel). B, HEK293 cells were transfected with the reporter gene plasmid 
containing the c-fos promoter fused to the luciferase gene, together with the indicated 
combinations of the plasmids expressing NF45, NF90, N90(FA), NF90(AP), NF110, 
NF110(FA), or NF110(AP) . Relative levels of the luciferase activities are shown, and the bars 
indicate standard error of the mean of three independent experiments. C, in vitro transcription 
reactions using the c-fos promoter were performed in the presence of NF45-NF90, 
NF45-NF90(FA), and NF45-NF90(AP) (upper panel), or in the presence of NF45-NF110, 
NF45-NF110(FA), and NF45-NF110(AP) (lower panel) as indicated above each lane. The NF 
complexes added to reactions were either 33 ng or 100 ng. SRF, Elk-1, CREB, ATF1, and PC4 
were included in the reactions indicated by +. The relative levels of transcripts are indicated 
below each panel. D, in vitro transcription reactions were performed as in C and the reactions 
contained 5 ng, 50 ng, or 500 ng of poly(I)·poly(C). E, in vitro transcription reactions were 
performed as in C and the reactions contained 5 ng, 50 ng, or 500 ng of total cellular RNA. 
 
FIGURE 4. siRNA-mediated knockdown of NF90 and NF110 diminishes rapid induction of 
the c-fos gene. A, C3H10T1/2 cells were treated with siRNA specific for NF90/NF110 
(NF90/NF110 KD) or control siRNA (control KD) for 48 h. The cell lysates were separated by 
SDS-PAGE and analyzed by immunoblots using anti-NF90/NF110 to determine the amounts of 
NF90 and NF110 in the cells. B-D, C3H10T1/2 cells were treated with siRNA for 48 h, and then 
the cells were starved for 24 h before stimulation by 20% serum, 25 ng/ml anisomycin or 5 
ng/ml EGF. The levels of the c-fos mRNA were determined by quantitative RT-PCR before (0 
min) and after 20% serum stimulation (B), 25 ng/ml anisomycin (C), or 5 ng/ml EGF (D) (15 
min, 30 min, 45 min, 60 min, 90 min, and 120 min). The P values for the differences in the c-fos 
mRNA levels between NF90/NF110 and control knockdown experiments: P=0.0331 (15 min, 
20 % serum), P=0.0054 (30 min, 20 % serum), P=0.0026 (30 min, 5 ng/ml EGF). The P values 
were >0.05 at all the other time points for 20% serum, 25 ng/ml anisomycin, and 5 ng/ml EGF. 
E-G, NF90/NF110 knockdown and c-fos induction was performed as in B-D. The expression of 
α-tubulin after treatment by 20% serum (E), 25 ng/ml anisomycin (F), or 5 ng/ml EGF (G) was 
analyzed by quantitative RT-PCR. The graphs show relative fold activations compared to 0 min, 
which were calculated and averaged from five experiments. The error bars indicate the standard 
error of the mean. 
 
FIGURE 5. Dynamic occupancies of NF45, NF90, and NF110 on the c-fos gene. A, structure 
of the c-fos gene. The boxes indicate the exons of the c-fos gene, in which the white boxes 
indicate its untranslated regions. The positions of SRE/FAP-1, CRE, the TATA box, and the 
transcription start site are indicated. The black bars indicate the positions of the amplified 
regions by PCR in the ChIP assays. B, ChIP assays were performed with C3H10T1/2 cells 
collected before (0 min) and after serum stimulation (30 min and 60 min). Antibodies against 
NF45, NF90/NF110, NF110, and RPB2 as well as control IgG were used for the ChIP assays as 
indicated above each panel. The error bars indicate standard error of the means of three 
independent experiments. 
 
FIGURE 6. The NF complexes act through the upstream regulatory elements and the core 
promoter of the c-fos gene. A, The reporter gene plasmids contained deletion mutants of the 
c-fos enhancer/promoter region as indicated on the left. Each reporter plasmid was transfected 
into C3H10T1/2 cells together with the plasmid expressing NF45 and that expressing NF90 or 
NF110. The middle panel shows the relative levels of the luciferase activities in the presence of 
NF45-NF90 or NF45-NF110. The columns on the right indicate the values of fold activation by 
NF45-NF90 and NF45-NF110. B, the structure of the reporter gene that harbors the wild-type or 
mutant c-fos gene promoter are indicated on the left. The filled boxes indicate the mutated SRE, 
NF45-NF90 and NF45-NF110 function as transcriptional coactivators 
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FAP-1, and CRE. The wild-type or mutant reporter gene was introduced into HEK293 cells with 
the expression vectors for NF45 and NF90, or those with NF45 and NF110. The middle panel 
shows the relative levels of the luciferase activities in the presence of NF45-NF90 or 
NF45-NF110. The bars indicate standard error of the mean of three independent experiments. 
The columns on the right indicate the values of fold activation by NF45-NF90 and 
NF45-NF110.  
 
FIGURE 7. The NF proteins interact with activators and the components of the basal 
transcriptional machinery. A, FLAG-tagged NF proteins or their complexes were tested for 
interactions with GST-fused activators retained on Glutathione Sepharose 4B. The bound 
proteins were separated by SDS-PAGE and visualized by immunoblots using anti-FLAG 
antibody. B, the TREF fraction (2.24 mg) or HeLa nuclear extract (4.67 mg) was used in place 
of purified NF complexes for interaction assays as performed in A. Anti-NF90/NF110 or 
anti-NF45 antibody was used to detect the NF proteins in the bound proteins. The amounts of 
bound proteins were 2.1%, 1.9%, 1.9%, 2.3%, and 2.0% of the TREF fraction for GST, 
GST-SRF, GST-Elk-1, GST-CREB, and GST-ATF1, respectively. Similarly, the amounts of 
bound proteins were 1.5%, 1.2%, 1.3%, 1.1%, and 1.0% of HeLa nuclear extract for GST, 
GST-SRF, GST-Elk-1, GST-CREB, and GST-ATF1, respectively. C, FLAG-tagged general 
transcription factors were tested for interactions with GST-fused NF proteins. In TFIIH and 
TFIID, MO15 and TBP were tagged with FLAG, respectively. In the complexes of NF45-NF90 
and NF45-NF110, NF45 was expressed as a GST-fusion protein and heterodimerized in insect 
cells with NF90 and NF110, respectively. The asterisk indicates a non-specific band. D, partially 
purified RNAPII from HeLa cells were tested for interactions with the NF proteins. IIo and IIa 
indicate the positions of hyperphosphorylated and unphosphorylated forms of RNAPII, 
respectively. RNGTT indicates RNA guanylyltransferase and 5'-phosphatase. 
 
FIGURE 8. Dynamic localization of the NF complexes during transcription and 
posttranscriptional processes. The NF complexes are present on the upstream regulatory 
elements as well as on the promoter. Upon the activation of the c-fos gene, they are transferred 
to RNAPII and become associated indirectly with RNAPII. After reaching the downstream of 
the gene, they bind to the mRNA and exported into cytoplasm. 
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